SHEL Stock Analysis: Shell | NYSE
Oil & Gas Integrated | NYSE, USA | Market Cap: 257.493m USD | 12M Return: 30.7% | US7802593050 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 513M
EPS Trend: -51.6%
Qual. Beats: 2
Rev. Trend: -79.8%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Shell plc is a London-headquartered energy and petrochemical company operating globally across five reportable segments: Integrated Gas, Upstream, Marketing, Chemicals and Products, and Renewables and Energy Solutions. Its operations span the full oil and gas value chain, from exploration and extraction of crude oil, natural gas, and natural gas liquids, through LNG production and gas-to-liquids (GTL) processing, to refining, chemicals manufacturing, marketing of fuels and lubricants, and an extensive pipeline and trading business.
In recent years, Shell has expanded into low-carbon energy offerings, including biofuels for aviation, marine, and agricultural customers, as well as electric vehicle charging and convenience retail through its marketing network. Founded in 1907 and originally listed as Royal Dutch Shell, the company adopted its current single-name structure in January 2022 and trades on the NYSE as an ADR under the ticker SHEL, classified within the GICS Energy sector.
The integrated business model-combining upstream production with midstream infrastructure, downstream refining, and chemicals-has historically been the dominant structure among the worlds largest oil majors, allowing these companies to capture margins across multiple stages of the hydrocarbon value chain while diversifying exposure to commodity price cycles.
- Crude oil and gas price swings drive upstream segment margins
- LNG demand and pricing growth supports Integrated Gas cash flows
- Share buyback program accelerates returning surplus capital to shareholders
| Net Income: 26.0b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.70 > 1.0 |
| NWC/Revenue: 12.55% < 20% (prev 10.87%; Δ 1.68% < -1%) |
| CFO/TA 0.13 > 3% & CFO 48.4b > Net Income 26.0b |
| Net Debt (72.3b) to EBITDA (66.1b): 1.09 < 3 |
| Current Ratio: 1.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.82b) vs 12m ago -6.12% < -2% |
| Gross Margin: 18.04% > 18% (prev 14.86%; Δ 3.18% > 0.5%) |
| Asset Turnover: 77.17% > 50% (prev 70.12%; Δ 7.05% > 0%) |
| Interest Coverage Ratio: 8.55 > 6 (EBIT TTM 43.3b / Interest Expense TTM 5.06b) |
| A: 0.10 (Total Current Assets 123b - Total Current Liabilities 85.6b) / Total Assets 381b |
| B: 0.42 (Retained Earnings 161b / Total Assets 381b) |
| C: 0.11 (EBIT TTM 43.3b / Avg Total Assets 384b) |
| D: 0.91 (Book Value of Equity 181b / Total Liabilities 199b) |
| Altman-Z'' = 3.73 = AA |
| DSRI: 1.07 (Receivables 52.9b/45.6b, Revenue 297b/272b) |
| GMI: 0.82 (GM 14.86% / 18.04%) |
| AQI: 0.96 (AQ_t 0.20 / AQ_t-1 0.21) |
| SGI: 1.09 (Revenue 297b / 272b) |
| TATA: -0.06 (NI 26.0b - CFO 48.4b) / TA 381b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of August 25, 2026, the stock is trading at USD 93.00 with a total of 5,658,574 shares traded. Over the past week, the price has changed by +1.51%, over one month by +6.15%, over three months by +10.33% and over the past year by +30.68%.
Current recommended Stop Loss: 90.70 (which is 2.5% or 1.5 ATR below the current price).
Shell has received a consensus analysts rating of 3.94. Therefore, it is recommended to buy SHEL.
- StrongBuy: 7
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 98 | 5.4% |
P/E Trailing = 10.3241
P/E Forward = 8.3752
P/S = 0.8681
P/B = 1.4243
P/EG = 1.3917
Revenue TTM = 297b USD
EBIT TTM = 43.3b USD
EBITDA TTM = 66.1b USD
Long Term Debt = 42.2b USD (from longTermDebt, last fiscal year)
Short Term Debt = 8.54b USD (from shortTermDebt, last quarter)
Debt = 104b USD (from shortLongTermDebtTotal, last quarter) + Leases 30.6b
Net Debt = 72.3b USD (calculated: Debt 104b - CCE 31.4b)
Enterprise Value = 330b USD (257b + Debt 104b - CCE 31.4b)
Interest Coverage Ratio = 8.55 (Ebit TTM 43.3b / Interest Expense TTM 5.06b)
EV/FCF = 10.71x (Enterprise Value 330b / FCF TTM 30.8b)
FCF Yield = 9.34% (FCF TTM 30.8b / Enterprise Value 330b)
FCF Margin = 10.39% (FCF TTM 30.8b / Revenue TTM 297b)
Net Margin = 8.76% (Net Income TTM 26.0b / Revenue TTM 297b)
Gross Margin = 18.04% ((Revenue TTM 297b - Cost of Revenue TTM 243b) / Revenue TTM)
Gross Margin QoQ = 19.52% (prev 19.28%)
Tobins Q-Ratio = 0.87 (Enterprise Value 330b / Total Assets 381b)
Interest Expense / Debt = 4.88% (Interest Expense 5.06b / Debt 104b)
Taxrate = 34.43% (13.7b / 39.9b)
NOPAT = 28.4b (EBIT 43.3b * (1 - 34.43%))
Current Ratio = 1.43 (Total Current Assets 123b / Total Current Liabilities 85.6b)
Debt / Equity = 0.57 (Debt 104b / totalStockholderEquity, last quarter 181b)
Debt / EBITDA = 1.09 (Net Debt 72.3b / EBITDA 66.1b)
Debt / FCF = 2.35 (Net Debt 72.3b / FCF TTM 30.8b)
Total Stockholder Equity = 176b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.76% (Net Income 26.0b / Total Assets 381b)
RoE = 14.74% (Net Income TTM 26.0b / Total Stockholder Equity 176b)
RoCE = 19.81% (EBIT 43.3b / Capital Employed (Equity 176b + L.T.Debt 42.2b))
RoIC = 9.83% (NOPAT 28.4b / Invested Capital 289b)
WACC = 5.71% (E(257b)/V(361b) * Re(6.72%) + D(104b)/V(361b) * Rd(4.88%) * (1-Tc(0.34)))
Discount Rate = 6.72% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.79 | Cagr: -6.16%
[DCF] Terminal Value 76.36% ; FCFF base≈30.0b ; Y1≈31.9b ; Y5≈38.1b
[DCF] Fair Price = 185.8 (EV 585b - Net Debt 72.3b = Equity 513b / Shares 2.76b; r=8.35% [WACC [floored]]; 5y FCF grow 7.37% → 2.50% )
EPS Correlation: -51.56 | EPS CAGR: -7.39% | SUE: 1.46 | # QB: 2
Revenue Correlation: -79.81 | Revenue CAGR: -6.40% | SUE: 1.23 | # QB: 1
EPS current Quarter (2026-09-30): EPS=2.83 | Chg30d=+5.50% | Revisions=+0% | Analysts=7
EPS current Year (2026-12-31): EPS=10.96 | Chg30d=+9.43% | Revisions=+22% | GrowthEPS=+73.9% | GrowthRev=+23.4%
EPS next Year (2027-12-31): EPS=8.82 | Chg30d=-0.38% | Revisions=-44% | GrowthEPS=-19.5% | GrowthRev=-10.3%
[Analyst] Revisions Ratio: -11% (up=7, down=9)